Brainsway (BWAY) Other Non-Current Assets (2018 - 2026)

Brainsway (BWAY) posted quarterly Other Non-Current Assets of $2.3 million for Q1 2026, down 30.16% year-on-year from $3.3 million in Q1 2025, and up 19.42% on a QoQ basis from $1.9 million in Q4 2025.

Brainsway (BWAY) Other Non-Current Assets (2018 - 2026) Analysis & Trends

Brainsway (BWAY) has reported Other Non-Current Assets for 9 consecutive years, with $2.3 million the latest figure, recorded in Q1 2026.

  • Quarterly Other Non-Current Assets fell 30.16% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (down 30.16% YoY) and the FY2025 annual result came in at $1.9 million, down 28.43% from the prior year.
  • Other Non-Current Assets grew to $2.3 million in Q1 2026 per BWAY's latest filing, from $1.9 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for BWAY reached as high as $3.9 million in Q2 2025 and fell as low as $863000.0 in Q3 2022.
  • A 5-year average of $2.0 million and a median of $1.9 million in 2024 frame the typical range for Other Non-Current Assets.
  • Annual changes were most pronounced in 2022 — Other Non-Current Assets soared 498.18% — and 2026, when it plunged 30.16%.
  • Year by year, Other Non-Current Assets stood at $1.0 million in 2022, then soared by 64.78% to $1.7 million in 2023, then soared by 57.13% to $2.7 million in 2024, then dropped by 28.43% to $1.9 million in 2025, then climbed by 19.42% to $2.3 million in 2026.
  • According to Business Quant data, Other Non-Current Assets over the past three periods registered $2.3 million, $1.9 million, and $3.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 3.17 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 4.15 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 2.05 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 738.90 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 285.90 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 828.89 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 2.25 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 164.00 Mn
10 Brainsway 646.63 Mn 587.74 Mn 11.68 Mn 2.31 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.31 Mn
Dec 31, 2025 1.93 Mn
Sep 30, 2025 3.55 Mn
Jun 30, 2025 3.90 Mn
Mar 31, 2025 3.30 Mn
Dec 31, 2024 2.70 Mn
Sep 30, 2024 2.27 Mn
Jun 30, 2024 2.05 Mn
Mar 31, 2024 1.88 Mn
Dec 31, 2023 1.72 Mn
Sep 30, 2023 1.40 Mn
Jun 30, 2023 1.22 Mn
Mar 31, 2023 1.06 Mn
Dec 31, 2022 1.04 Mn
Sep 30, 2022 863,000.00
Jun 30, 2022 999,000.00
Mar 31, 2022 987,000.00
Dec 31, 2021 954,000.00
Sep 30, 2021 175,000.00
Jun 30, 2021 280,000.00